Literature DB >> 21480414

The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.

Sidney J Stohs1, Harry G Preuss, Mohd Shara.   

Abstract

Citrus aurantium (bitter orange) extract and its principal protoalkaloidal constituent p-synephrine are widely used in weight loss and weight management as well as in sports performance products. However, questions are raised frequently regarding the safety of these ingredients. The potential inherent dangers associated with the use of products containing C. aurantium extract are frequently touted, while conversely, millions of doses of dietary supplements have been consumed by possibly millions of individuals in recent years. Furthermore, millions of people consume on a daily basis various juices and food products from Citrus species that contain p-synephrine. This review summarizes current information regarding the safety of C. aurantium (bitter orange) extract and p-synephrine based on human, animal and in vitro assessments as well as receptor binding and mechanistic studies. The data indicate that based on current knowledge, the use of bitter orange extract and p-synephrine appears to be exceedingly safe with no serious adverse effects being directly attributable to these ingredients.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21480414     DOI: 10.1002/ptr.3490

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  33 in total

Review 1.  Oral herbal therapies for treating osteoarthritis.

Authors:  Melainie Cameron; Sigrun Chrubasik
Journal:  Cochrane Database Syst Rev       Date:  2014-05-22

Review 2.  New Dietary Supplements for Obesity: What We Currently Know.

Authors:  Alejandro Ríos-Hoyo; Gabriela Gutiérrez-Salmeán
Journal:  Curr Obes Rep       Date:  2016-06

3.  Atrial Fibrillation Due to Over The Counter Stimulant Drugs in A Young Adult.

Authors:  Braghadheeswar Thyagarajan; Sayee Sundar Alagusundaramoorthy; Abhinav Agrawal
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 4.  Nutritional and non-nutritional agents that stimulate white adipose tissue browning.

Authors:  F Concha; G Prado; J Quezada; A Ramirez; N Bravo; C Flores; J J Herrera; N Lopez; D Uribe; L Duarte-Silva; P Lopez-Legarrea; Diego F Garcia-Diaz
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

5.  Problems with Citrus aurantium information in "A review on botanical species and chemical compounds with appetite suppressing properties for body weight control".

Authors:  Sidney J Stohs
Journal:  Plant Foods Hum Nutr       Date:  2013-09       Impact factor: 3.921

6.  Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity.

Authors:  Jessica L Verpeut; Amy L Walters; Nicholas T Bello
Journal:  Nutr Res       Date:  2013-05-08       Impact factor: 3.315

Review 7.  Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements.

Authors:  Luigi Barrea; Barbara Altieri; Barbara Polese; Barbara De Conno; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2019-04-12

8.  p-Synephrine suppresses glucose production but not lipid accumulation in H4IIE liver cells.

Authors:  Zhigang Cui; Youngil Lee; Youngki Lee; Deokbae Park
Journal:  J Med Food       Date:  2015-01       Impact factor: 2.786

9.  Some questionable conclusions in the article "Dietary supplements and hypertension: potential benefits and precautions".

Authors:  Sidney J Stohs
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-09-12       Impact factor: 3.738

Review 10.  A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.

Authors:  Sidney J Stohs; Harry G Preuss; Mohd Shara
Journal:  Int J Med Sci       Date:  2012-08-29       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.